124 related articles for article (PubMed ID: 30545658)
1. The efficacy of double filtration plasmapheresis in the treatment of homozygous familial hypercholesterolemia: A single-center experience.
Albayrak M; Yıldız A; Ateş N; Pala Ç
Transfus Apher Sci; 2019 Feb; 58(1):61-64. PubMed ID: 30545658
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-Up of a Homozygous Familial Hypercholesterolemic Patient Receiving Regular Double Filtration Plasmapheresis - Case Report and Literature Review.
Tsai JL; Wu MJ; Shu KH; Tsai SF
Blood Purif; 2016; 41(4):264-9. PubMed ID: 26731699
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
Gordon BR; Saal SD
J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
[TBL] [Abstract][Full Text] [Related]
4. From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
Klingel R; Fassbender T; Fassbender C; Göhlen B
Ther Apher Dial; 2003 Jun; 7(3):350-8. PubMed ID: 12924612
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein apheresis efficacy and challenges: single center experience.
Özdemir ZN; Şahin U; Yıldırım Y; Kaya CT; İlhan O
Hematol Transfus Cell Ther; 2022; 44(1):56-62. PubMed ID: 33745887
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.
Suzuki M; Yamane S; Matsugane T; Nobuto T; Azuma N; Nishide T; Shinomiya M; Saito K; Sasaki N; Nosé Y
Artif Organs; 1996 Apr; 20(4):296-302. PubMed ID: 8860710
[TBL] [Abstract][Full Text] [Related]
7. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood.
Gokay S; Kendirci M; Kaynar L; Solmaz M; Cetin A; Kardas F; Soylu Ustkoyuncu P
Transfus Apher Sci; 2016 Apr; 54(2):282-8. PubMed ID: 26577019
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
Fernández-Fuertes LF; Tapia Martín M; Nieves Plá I; Novoa Mogollón FJ; Díaz Cremades J
Ther Apher Dial; 2010 Oct; 14(5):484-5. PubMed ID: 21175548
[No Abstract] [Full Text] [Related]
10. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
11. Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia.
Taylan C; Schlune A; Meissner T; Ažukaitis K; Udink Ten Cate FE; Weber LT
J Clin Lipidol; 2016; 10(6):1303-1310. PubMed ID: 27919346
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of homozygous familial hypercholesterolemia using cascade filtration plasmapheresis.
Kardaş F; Cetin A; Solmaz M; Büyükoğlan R; Kaynar L; Kendirci M; Eser B; Unal A
Turk J Haematol; 2012 Dec; 29(4):334-41. PubMed ID: 24385721
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
Lee WP; Datta BN; Ong BB; Rees A; Halcox J
Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein apheresis in the management of severe hypercholesterolemia and hyperlipoproteinemia(a)-The Portuguese experience.
Ferreira L; Palma I; Bacelar C; Queirós JA; Madureira A; Oliveira JC; Ramos MH; Cardoso H
Transfus Apher Sci; 2018 Oct; 57(5):676-680. PubMed ID: 30287070
[TBL] [Abstract][Full Text] [Related]
15. Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction.
Raina R; Young C; Krishnappa V; Chanchlani R
Blood Purif; 2019; 47(4):301-316. PubMed ID: 30799420
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis.
Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Aukrust P; Retterstøl K; Ose L; Halvorsen B; Holven KB
J Clin Lipidol; 2013; 7(2):109-16. PubMed ID: 23415429
[TBL] [Abstract][Full Text] [Related]
17. Familial homozygous hypercholesterolemia: effective long-term treatment with cascade double filtration plasmapheresis.
Demetriou K; H'Maltezou E; Pierides AM
Blood Purif; 2001; 19(3):308-13. PubMed ID: 11244191
[TBL] [Abstract][Full Text] [Related]
18. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia.
Galán Carrillo I; Demelo-Rodriguez P; Rodríguez Ferrero ML; Anaya F
J Clin Lipidol; 2015; 9(5):698-702. PubMed ID: 26350817
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP; Armstrong VW; Zapf A; Bramlage P; Mueller GA; Koziolek MJ
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
